Daily Archives: February 23, 2022


Injectable PrEP highly successful, despite HIV infections Experts say breakthrough HIV should still remain rare in those receiving ViiV Healthcare’s injectable Apretude to prevent infection. In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite […]

Breakthrough HIV reported in injectable PrEP trial; experts say drug ...